SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-061128
Filing Date
2023-11-08
Accepted
2023-11-08 16:14:29
Documents
76
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q acet-20230930.htm   iXBRL 10-Q 2440579
2 EX-10.1 acet-ex10_1.htm EX-10.1 103570
3 EX-31.1 acet-ex31_1.htm EX-31.1 16914
4 EX-31.2 acet-ex31_2.htm EX-31.2 17110
5 EX-32.1 acet-ex32_1.htm EX-32.1 13427
  Complete submission text file 0000950170-23-061128.txt   8636052

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT acet-20230930_def.xml EX-101.DEF 237250
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20230930_pre.xml EX-101.PRE 410170
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT acet-20230930_cal.xml EX-101.CAL 50881
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20230930.xsd EX-101.SCH 75594
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20230930_lab.xml EX-101.LAB 552992
70 EXTRACTED XBRL INSTANCE DOCUMENT acet-20230930_htm.xml XML 1301754
Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38359 | Film No.: 231388025
SIC: 2834 Pharmaceutical Preparations